Proactive Investors - Run By Investors For Investors

Physiomics zips higher with trading ahead of expectations

The AIM-quoted firm expects revenues to almost double from last year, while losses should be “materially” lower than current market forecasts
doctors looking at x-ray
Physiomics’ technology can predict what effect a drug might have on a tumour

Physiomics Plc (LON:PYC) surged at the opening bell on Thursday after telling investors it is trading ahead of expectations as it approaches the end of its year.

The company, whose technology can predict the effect a drug might have on a cancer, expects full-year income to be greater than £495,000 – almost double the £270,500 it generated in 2017.

READ: Physiomics ready to build on Merck Serono landmark

A multi-year, £440,000 contract signed with German Firm Merck KgaA (not that Merck) back in November has been key to the outperformance.

The growth will translate into a healthier bottom line as well, with Physiomics adding that losses should be “materially” lower than current forecasts.

“We are pleased that as a result of the hard work of the team, the company continues to show progress not only in attracting new clients but in translating this into bookable revenue which is moving us closer to profitability,” said chief executive Jim Millen.

Shares zipped 11% higher to 4.7p in early deals in London.

View full PYC profile View Profile

Physiomics Plc Timeline

Related Articles

June 07 2019
Geremy Thomas, founder and chief executive of Sativa, said the company has "delivered expeditiously on its investment promise to the market"
harley street
May 10 2019
Work at Advanced Onco’s Harley Street facility is due to complete within the next few months, and the first patient treated by LIGHT is slated for the second half of 2020
healthy gut
July 15 2019
Here we take a look at AIM-listed life sciences group, OptiBiotix Health

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use